HBIO Harvard Bioscience Inc.
Exchange
NASDAQSector
Capital GoodsIndustry
Biotechnology: Laboratory Analytical InstrumentsMarket Cap.
156.6M
Grade
39.91/100
Current Price
$5.21
+0.18 (+3.58%) Company Metrics
- 81.13 P/E
- 1.39 P/S
- 1.45 P/B
- 0.062 EPS
- 13.42% Cash ROIC
- 1.87 Cash Ratio
- 0 / 0% Dividend
- 179,494.00 Avg. Vol.
- 30.06M Shares
- 156.6M Market Cap.
Company Description
Harvard Bioscience, Inc. develops, manufactures, and markets apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, universities, and government laboratories in the United States and internationally. The company's products target ADMET testing, and molecular biology and liquid handling application areas. Its ADMET testing products comprise...
more
News
Graziano retires as head of Harvard Bioscience, interim CEO named
Boston Business Journal (blog) - May 15, 2013
Harvard Bioscience CEO Graziano will retire - MSN Money
Boston Business Journal (blog) - May 15, 2013
Chane Graziano, CEO and director of Harvard Bioscience Inc. (Nasdaq: HBIO) in Holliston, Mass., has retired after 17 years in the position.
Harvard Bioscience Announces Retirement of CEO and Appointment of Interim ... - NASDAQ (press release)Harvard Bioscience CEO Graziano will retire - MSN Money
HARVARD BIOSCIENCE, INC. : HBIO Affirms Plan to Spin-Off Harvard ...
4-traders (press release) - May 1, 2013
4-traders (press release) - May 1, 2013
HOLLISTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it ...
HBIO Reports First Quarter 2013 Results - MarketWatch (press release) Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May ...
NASDAQ (press release) - Apr 26, 2013
NASDAQ (press release) - Apr 26, 2013
HOLLISTON, Mass., April 26, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, ...
Harvard Bioscience to Participate in Press Conference Today to Discuss ...
GlobeNewswire (press release) - Apr 30, 2013
Webcast Now Available of Press Conference Discussing Landmark Surgery ... - NASDAQ (press release)
GlobeNewswire (press release) - Apr 30, 2013
HOLLISTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, will participate in a ...
HARVARD BIOSCIENCE, INC. : Photo Release -- Harvard Apparatus ... - 4-traders (press release)Webcast Now Available of Press Conference Discussing Landmark Surgery ... - NASDAQ (press release)
AGEN's Brain Cancer Vaccine Works, AVEO On Watch, PSDV Gets Decision Date
NASDAQ - May 2, 2013
NASDAQ - May 2, 2013
Harvard Bioscience, Inc. ( HBIO ) affirmed its plan to spin-off its wholly-owned regenerative medicine device subsidiary - Harvard Apparatus Regenerative Technology Inc., or HART, to maximize value for its shareholders.
Scientists Implant Lab-Made Trachea Into Toddler
Wall Street Journal- India - Apr 30, 2013
Wall Street Journal- India - Apr 30, 2013
"If the body knows how to do this for the trachea, maybe it knows how to do this for other organs, too," said David Green, president of Harvard Bioscience Inc., of Holliston, Mass., which built the lab-made windpipe. He said the next step is to attempt ...
Gov. Perry Appoints Eight Members To The Texas Medical Board
BioNews Texas - May 20, 2013
BioNews Texas - May 20, 2013
Frank Denton of Conroe is president of Denton Investment Corp., Denton Investment Corporation, a stock, bond and real estate investment company.
DIARY-NON S&P WEEK AHEAD
Reuters - May 2, 2013
Reuters - May 2, 2013
... AMC Q1 2013 GUIDANCE SOFTWARE INC -0.03 3 0.02 02 May AMC Q3 2013 The Hain Celestial Group 0.72 12 0.54 02 May AMC Q2 2013 Haynes International Inc 0.55 5 1.23 02 May BMO Q1 2013 Harvard Bioscience, Inc. N/A N/A N/A 02 May BMO ...
ProfNet Roundup: 2013 Commencement Speakers
Wall Street Journal (press release) - May 8, 2013
Wall Street Journal (press release) - May 8, 2013
LaNier also serves as president of the Little Rock Nine Foundation, and is a member of the Denver Chapter of The Links, Incorporated, and the Johnson Legacy, Inc. board of directors. LaNier has received numerous awards and recognitions, including the ...
Wisconsin looks to reverse trend of poor venture capital investment
Milwaukee Journal Sentinel - Apr 26, 2013
Milwaukee Journal Sentinel - Apr 26, 2013
"We know how entrepreneurial communities get built - by entrepreneurs from the bottom up," said Greg Meier, a Milwaukee entrepreneur who is director of VETransfer Inc., which helps accelerate veteran-run start-ups. "The entrepreneurs in this community ...


